Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OMEPRAZOLE Cause Multiple drug therapy? 104 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 104 reports of Multiple drug therapy have been filed in association with OMEPRAZOLE (omeprazole sodium bicarbonate). This represents 0.1% of all adverse event reports for OMEPRAZOLE.

104
Reports of Multiple drug therapy with OMEPRAZOLE
0.1%
of all OMEPRAZOLE reports
11
Deaths
100
Hospitalizations

How Dangerous Is Multiple drug therapy From OMEPRAZOLE?

Of the 104 reports, 11 (10.6%) resulted in death, 100 (96.2%) required hospitalization, and 41 (39.4%) were considered life-threatening.

Is Multiple drug therapy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OMEPRAZOLE. However, 104 reports have been filed with the FAERS database.

What Other Side Effects Does OMEPRAZOLE Cause?

Chronic kidney disease (35,759) Acute kidney injury (19,260) Renal failure (14,721) End stage renal disease (10,356) Renal injury (9,482) Tubulointerstitial nephritis (4,809) Drug ineffective (4,355) Gastrooesophageal reflux disease (3,929) Pain (3,602) Nephrogenic anaemia (2,873)

What Other Drugs Cause Multiple drug therapy?

AMLODIPINE (136) LEVOTHYROXINE (133) FUROSEMIDE (132) ALBUTEROL (122) ACEBUTOLOL (104) ACETAMINOPHEN (98) ASPIRIN (98) QUETIAPINE (97) AMITRIPTYLINE (84) CALCIUM (82)

Which OMEPRAZOLE Alternatives Have Lower Multiple drug therapy Risk?

OMEPRAZOLE vs OMEPRAZOLE\SODIUM BICARBONATE OMEPRAZOLE vs OMNIPAQUE OMEPRAZOLE vs OMNISCAN OMEPRAZOLE vs ONABOTULINUMTOXINA OMEPRAZOLE vs ONASEMNOGENE ABEPARVOVEC

Related Pages

OMEPRAZOLE Full Profile All Multiple drug therapy Reports All Drugs Causing Multiple drug therapy OMEPRAZOLE Demographics